← Encyclopedia Cognitive and Neurological

Omberacetam (Noopept)

🔹 What is Omberacetam (Noopept)?

Class: Synthetic dipeptide-derived nootropic — technically an ethyl ester of a cyclic prolylglycine dipeptide. Often loosely grouped with “racetam” nootropics due to shared naming conventions and use cases, though structurally distinct from true racetams like piracetam. Mechanism:

  • Modulates NMDA and AMPA glutamate receptors, supporting the synaptic signaling underlying learning and memory formation.
  • Increases expression of NGF (nerve growth factor) and BDNF, supporting neuroplasticity and longer-term neuronal health.
  • Reported to act quickly relative to true racetams, with users commonly describing noticeable focus and clarity effects within the same day.

Primary focus:

  • Memory and learning enhancement.
  • Focus and mental clarity support.
  • General nootropic use in the biohacking/cognitive-enhancement community, where it is one of the most widely recognized and discussed compounds.

🔹 Oral Dosage (only practical route) Range:

  • Typically 10–30 mg per dose.

Frequency:

  • Commonly dosed 2–3 times daily, often sublingually (held under the tongue) rather than swallowed, for faster absorption and onset.

Rationale: Omberacetam is orally active and does not require injection — it stands out on this site as one of the more accessible compounds, sold as an approved prescription drug in Russia and available as an over-the-counter dietary supplement in the US and many other countries. Sublingual administration is favored by many users for quicker onset compared to swallowing a capsule.


🔹 Cycle Length Common cycle length: Often used in ongoing daily cycles of 4–8 weeks, though many users take it more continuously given its OTC availability and generally mild side-effect profile. Off-cycle: Periodic breaks are sometimes taken to reassess baseline cognitive function and avoid tolerance, though this is less rigidly enforced than with injectable peptide-based nootropics.


Educational Integration Example (oral)

  • Example protocol: 10–20 mg sublingually, 2–3 times daily, used as a standalone daily nootropic or as part of a broader cognitive-support stack.
  • Frequently discussed alongside choline sources (such as Alpha-GPC or CDP-choline), since glutamatergic nootropics are often paired with choline donors in general nootropic-stacking practice.

🔹 Stacking Strategy (Educational / Complementary) Since Omberacetam works through glutamate receptor modulation and NGF/BDNF upregulation, complementary stacks in the broader nootropic community tend to focus on supporting neurotransmitter substrate and general brain-support pathways: 🔸 Choline Support:

  • Alpha-GPC, CDP-choline: Commonly paired with glutamatergic nootropics to support acetylcholine synthesis alongside glutamate-pathway activity.

🔸 Peptide Nootropics:

  • Semax, Selank: Sometimes discussed alongside Omberacetam for a combined peptide-plus-small-molecule nootropic approach, given the different but complementary mechanisms (BDNF/dopaminergic vs. glutamatergic).

Rationale: Omberacetam’s mechanism is distinct enough from peptide-based nootropics that it is often treated as a separate pillar of a broader cognitive-support routine rather than a substitute for compounds like Semax or Selank.

Studied in Humans? Yes

FDA Approved? No (approved prescription drug in Russia; sold as an OTC dietary supplement in the US)

Allowed for 503a Compounding Pharmacy? No

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.